Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characteristics of the terminal phase of chronic granulocytic leukemia.

× No keyword cloud information.

12 in total

1. Therapy-linked leukemia.

Authors:
Journal: Br Med J Date: 1971-09-25

2. Utility of surgery in the treatment of epidural vertebral metastases.

Authors: A García-Picazo; P Capilla Ramírez; P Pulido Rivas; R Garcia de Sola
Journal: Acta Neurochir (Wien) Date: 1990 Impact factor: 2.216

3. Splenectomy for splenomegaly and secondary hypersplenism.

Authors: W W Coon
Journal: World J Surg Date: 1985-06 Impact factor: 3.352

4. HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

Authors: Paolo Strati; Hagop Kantarjian; Deborah Thomas; Susan O'Brien; Sergej Konoplev; Jeffrey L Jorgensen; Raja Luthra; Lynne Abruzzo; Elias Jabbour; Alfonso Quintas-Cardama; Gautam Borthakur; Stefan Faderl; Farhad Ravandi; Jorge Cortes
Journal: Cancer Date: 2013-10-22 Impact factor: 6.860

5. The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up.

Authors: Francesca Palandri; Fausto Castagnetti; Giuliana Alimena; Nicoletta Testoni; Massimo Breccia; Simona Luatti; Giovanna Rege-Cambrin; Fabio Stagno; Giorgina Specchia; Bruno Martino; Luciano Levato; Serena Merante; Anna Maria Liberati; Fabrizio Pane; Giuseppe Saglio; Daniele Alberti; Giovanni Martinelli; Michele Baccarani; Gianantonio Rosti
Journal: Haematologica Date: 2009-01-14 Impact factor: 9.941

6. Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation.

Authors: R Liang; T K Chan; E Chiu; D Todd
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 7. Accelerated and blastic phase of chronic myeloid leukemia.

Authors: J P Dutcher; P H Wiernik
Journal: Curr Treat Options Oncol Date: 2000-04

8. Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone.

Authors: Z A Arlin; E Berman; S Jhanwar; R Gams; I Schoch; G Dukart
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

9. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.

Authors: A Grossman; R T Silver; Z Arlin; M Coleman; E Camposano; P Gascon; P A Benn
Journal: Am J Hum Genet Date: 1989-11 Impact factor: 11.025

10. Chronic myeloproliferative disorders: prognostic importance of new working classification.

Authors: R Burkhardt; K Jaeger; G Kettner; G Helmer
Journal: J Clin Pathol Date: 1990-05 Impact factor: 3.411